Search Page

1

Cite

Share

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.

Kennedy NA, Lin S, Goodhand JR, Chanchlani N, Hamilton B, Bewshea C, Nice R, Chee D, Cummings JF, Fraser A, Irving PM, Kamperidis N, Kok KB, Lamb CA, Macdonald J, Mehta S, Pollok RC, Raine T, Smith PJ, Verma AM, Jochum S, McDonald TJ, Sebastian S, Lees CW, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Among authors: kamperidis n. Gut. 2021 Oct;70(10):1884-1893. doi: 10.1136/gutjnl-2021-324789. Epub 2021 Apr 26. Gut. 2021. PMID: 33903149 Free PMC article.

Cite

Share

2

Cite

Share

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives.

Papamichael K, Afif W, Drobne D, Dubinsky MC, Ferrante M, Irving PM, Kamperidis N, Kobayashi T, Kotze PG, Lambert J, Noor NM, Roblin X, Roda G, Vande Casteele N, Yarur AJ, Arebi N, Danese S, Paul S, Sandborn WJ, Vermeire S, Cheifetz AS, Peyrin-Biroulet L; International Consortium for Therapeutic Drug Monitoring. Papamichael K, et al. Among authors: kamperidis n. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):171-185. doi: 10.1016/S2468-1253(21)00223-5. Lancet Gastroenterol Hepatol. 2022. PMID: 35026171 Review.

Cite

Share

3

Cite

Share

Atherosclerosis and Inflammatory Bowel Disease-Shared Pathogenesis and Implications for Treatment.

Kamperidis N, Kamperidis V, Zegkos T, Kostourou I, Nikolaidou O, Arebi N, Karvounis H. Kamperidis N, et al. Angiology. 2021 Apr;72(4):303-314. doi: 10.1177/0003319720974552. Epub 2020 Dec 2. Angiology. 2021. PMID: 33601945 Review.

Cite

Share

4

Cite

Share

Neurological disorders and small bowel dysmotility.

Kamperidis N, Nightingale J. Kamperidis N, et al. Curr Opin Gastroenterol. 2022 May 1;38(3):299-306. doi: 10.1097/MOG.0000000000000836. Curr Opin Gastroenterol. 2022. PMID: 35645022 Review.

Cite

Share

5

Cite

Share

Response to the Letter Regarding: Atherosclerosis and Other Cardiac Manifestations in Inflammatory Bowel Disease.

Kamperidis V, Kamperidis N. Kamperidis V, et al. Among authors: kamperidis n. Angiology. 2021 Jul;72(6):594-595. doi: 10.1177/00033197211003438. Epub 2021 Apr 5. Angiology. 2021. PMID: 33813909 No abstract available.

Cite

Share

6

Cite

Share

Single incision laparoscopic assisted double balloon enteroscopy: a novel technique to manage small bowel pathology.

Stasinos I, Kamperidis N, Murino A, Jenkins JT, Warusavitarne J, Fraser C, Humphries A. Stasinos I, et al. Among authors: kamperidis n. Surg Endosc. 2020 Jun;34(6):2773-2779. doi: 10.1007/s00464-020-07446-2. Epub 2020 Feb 18. Surg Endosc. 2020. PMID: 32072281

Cite

Share

7

Cite

Share

A User's Guide to De-Escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.

Arebi N, Dyall L, Kamperidis N. Arebi N, et al. Among authors: kamperidis n. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1300-1301. doi: 10.1016/j.cgh.2020.06.056. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248077 No abstract available.

Cite

Share

8

Cite

Share

Prevalence of malnutrition in medical and surgical gastrointestinal outpatients.

Kamperidis N, Tesser L, Wolfson P, Toms C, Katechia K, Robinson D, Nightingale J. Kamperidis N, et al. Clin Nutr ESPEN. 2020 Feb;35:188-193. doi: 10.1016/j.clnesp.2019.10.002. Epub 2019 Oct 31. Clin Nutr ESPEN. 2020. PMID: 31987115

Cite

Share

9

Cite

Share

Caveats of Retrospective Data Analyses from Therapeutic Drug Monitoring Clinical Pathways.

Kamperidis N, Stasinos I, Arebi N. Kamperidis N, et al. J Crohns Colitis. 2020 Jul 9;14(6):876-877. doi: 10.1093/ecco-jcc/jjz190. J Crohns Colitis. 2020. PMID: 31761934 No abstract available.

Cite

Share

10

Cite

Share

The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery.

Kamperidis N, Faiz O, Arebi N. Kamperidis N, et al. Ann Surg. 2017 Dec;266(6):e61-e62. doi: 10.1097/SLA.0000000000001502. Ann Surg. 2017. PMID: 29136975 No abstract available.

Cite

Share